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Frailty is a major health condition associated with ageing. Although the concept is almost universally accepted,
its operational definition remains controversial. Anyway, this geriatric condition represents a huge potential public
health issue at both the patient and the societal levels because of its multiple clinical, societal consequences and
its dynamic nature. Here, we review existing definitions and assessment tools for frailty, we highlight consequences
of this geriatric condition and we discuss the importance of its screening and prevention to limit its public
health burden.
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Frailty is a state of increased vulnerability to poor reso-
lution of homoeostasis after a stressor event and increases
the risk of adverse outcomes, including falls, delirium, and
disability [1,2]. Frailty is the consequence of accumulated
age-related defects in different physiological systems [3].
According to the World Health Organization, the global
population of elderly people aged 60 years or more was
600 million in 2000; it is expected to rise to around 2
billion by 2050 [4]. With an aging population, there is a
growing interest for frailty [5]. Indeed, a quarter to a half
of people older than 85 years are estimated to be frail [1].
However, frailty remains an evolving concept lacking both
a unique definition and diagnostic criteria to be used in
clinical practice and epidemiological researches [6,7].
While researchers, policy makers and health care pro-
viders generally agree that frailty can have an important
impact on affected individuals, their families, the health
care system and the society, the concept of frailty remains
controversial [5]. From a clinical perspective, frailty is cru-
cial because it constitutes a condition of greater risk of
adverse health outcomes, such as falls, hospitalization, dis-
ability and death [8]. Frailty is important from a societal
perspective because it identifies groups of people in need* Correspondence: fanny.buckinx@ulg.ac.be
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Frailty is also on concern when considering financial
health care planning to better select management and pre-
vention programs. Finally, as suggested in some recent
studies, the frailty status might be reversible with the im-
plementation of specific exercises programs [9-11] and
nutritional supplementation [12,13]. Therefore identify
frail elderly subjects is essential.
This work was not intended to be a systematic review
but only to be a thematic one conducted by epidemiolo-
gists and geriatricians. Therefore, the purpose of this
study was to review the recent literature on the defin-
ition of frailty, the burden of the disease and the chal-
lenges for public health (i.e. screening and prevention).
To select the most recent articles, we carried out a
search in the electronic database MEDLINE to identify
studies published within the last 20 years. We also lim-
ited our search to articles about human frailty, written in
English or French and concerning people aged over
65 years. The mesh term « frailty » was used in this re-
search and to refine the search, the term “definition”,
“prevalence”, “epidemiology”, “screening”, “consequences”
and “intervention” were combined with “frailty” using
Boolean indicators. Additional studies were identified by a
manual search of bibliographic references of selected arti-
cles and existing reviews. More than 2300 articles were
found. The most interesting references were selected on
the basis of the previously reported goals (Figure 1).l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Flowchart of litterature search. Flowchart showing study selection for this review of the literature on frailty among elderly.
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Controversies in frailty definition
Frailty is a concept that has been used in clinical and re-
search fields for more than two decades [14]. It is usually
described as a clinical state of increased vulnerability to
poor resolution of homoeostasis after a stressor event
which increases the risk of adverse outcomes, including
falls, delirium, and disability [1,2,8]. The European Union
has placed specific importance on defining precisely frailty
because, from an economic point of view, frail persons are
high users of community resources such as hospitalization
and institutionalization [2]. It is important to note that all
frail elderly subjects do not experience the same symp-
toms and consequences and that frailty is not related to
specific diseases, but is rather more present as a combin-
ation of consequences of co-morbidity [8]. In the last few
years, frailty has been acknowledged to be not only a bio-
logical or physiological problem, but mainly a multidi-
mensional concept [15]. Recently, an integral conceptual
model of frailty reflecting part of the current thinking on
frailty was established. This model uses the following def-
inition which illustrates well this new concept: “Frailty is a
dynamic state affecting an individual who experiences
losses in one or more domains of human functioning
(physical, psychological, and social), which is caused by
the influence of a range of variables and which increases
the risk of adverse outcomes [16]”. This definition reflects
the changeability of frailty over time and emphasizes that
the interacting factors in the physical, psychological and
social domains are part of a complex dynamic system [15].
Moreover, some recent works consider cognition in the
definition of frailty [1,17]. Based on an international con-
sensus, “cognitive frailty” is an heterogeneous clinical
manifestation characterized by simultaneous presence of
both physical frailty and cognitive impairments [18]. The
definition implies that cognitive frailty is characterized byreduced cognitive reserves, but is different from the
physiological brain aging [19].
Thus, no consensus about the definition of frailty emerges
from the literature. Despite significant work over the past
decades, the debate continues between normal ageing on
one hand, and pathophysiological entity on the other [14].
The choice of which components have to be included in
the frailty definition continues to be a contentious issue
with important implications. For example, although some
authors have included disability and functional decline as
components of frailty, others consider disability and func-
tional decline as outcomes [20]. Moreover, within each of
the physical, psychological and social dimensions, various
determinants for frailty exist. Consequently, numerous as-
sessment tools of frailty have been developed, generally on
the basis of one or the other of these definitions. Most
tools include a pre-frailty state allowing the identification
of a subset of subjects at high risk of progressing to frailty
[21]. These tools are grouped into three categories: sub-
jective (self-report only), objective (inclusion of only dir-
ectly measured components) or subjective and objective
combined (mixed) [22].
Assessment tools to identify frailty
Several frailty scales have been proposed on the basis of
different conceptual models of frailty and two approaches
have become popular [21]. The first model, or deficit
model, consists of adding together individual’s number of
impairments and conditions to create a Frailty Index [23].
This model consider frailty as a multidimensional risk
state that can be measured more by the quantity than by
the nature of health problems [24]. The second model,
originally, defined a specific physical phenotype of frailty.
This model views frailty as a biological syndrome resulting
from cumulative decline across multiple physiological sys-
tems [24]. Other operational concepts of frailty can be
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[15,25,26]. According to Cesari [19], it is inappropriate
to consider the frailty phenotype and the frailty index
as alternatives or substitutable models. These two in-
struments are different and should rather be consid-
ered as complementary.
To our current knowledge, the instruments described
below are frequently cited in the literature as validated
tools to measure frailty.
 Frailty phenotype: Fried [8] defines a phenotype of
frailty by the presence of three or more of the
following components: shrinking, weakness, poor
endurance and energy, slowness and low physical
activity level. Presence of one or two deficits
indicates a prefrail condition, while the absence of
deficit indicates a robust state.
 Strawbridge questionnaire: The questionnaire
developed by Strawbridge in 1998 [27], defines
frailty as difficulty in two or more functional
domains (physical, cognitive, sensory, and nutritive).
 Edmonton Frail Scale (EFS): The EFS samples 8
domains (Cognitive impairment, health attitudes,
social support, medication use, nutrition, mood,
continence and functional abilities). The maximum
score is 17 and represents the highest level of frailty
[28]. A score range between 0 and 3 defines a robust
state, a score of 4 or 5 corresponds to the slightly frail
state, a score range between 6 and 8 corresponds to
the moderately frail state and a score range between 9
and 17 corresponds to the severely frail state.
 Clinical Frailty Scale (CFS): CSF is based on a
clinical evaluation in the domains of mobility,
energy, physical activity and function. The scale uses
descriptors, icons and figures to stratify older adults
according to their level of vulnerability and the
score ranges from 1 (robust health) to 7 (complete
functional dependence on others) [17].
 FRAIL Scale: The Frail Scale includes 5 components
and considers deficits accumulated in these 5
domains, forming its acronym: Fatigue, Resistance,
Ambulation, Illness, and Loss of weight. Frail
scale scores range from 0–5 (i.e., 1 point for each
component; 0 = best to 5 = worst) and represent
frail (3–5), pre-frail (1–2), and robust (0) health
status [29,30].
 Groningen Frailty Indicator (GgugFI) : The GFI
consists of 15 self-report items and screens for loss
of functions and resources in four domains: physical,
cognitive, social, and psychological. Scores range
from zero (not frail) to fifteen (very frail). A score of
GFI of 4 or higher is regarded as frail [31].
 Share Frailty Instrument (Share-FI) : Using the five
SHARE frailty variables (fatigue, loss of appetite, gripstrength, functional difficulties and physical activity),
DFactor scores (DFS) were determined using the
SHARE-FI formula and based on the DFS value,
the subject could then be categorized as non-frail,
pre-frail, or frail [32].
 Tilburg Frailty Indicator (TFI): The TFI consists of 2
parts. Part A contains 10 questions on determinants
of frailty and diseases (multi-morbidity); part B
contains 3 domains of frailty (quality of life,
disability, and healthcare utilization) with a
total of 15 questions on components of frailty.
The cut off point for frailty is defined as
5 points [33].
 Frailty index: The index is often expressed as a ratio
of deficits present to the total number of deficits
considered. It shows a consistent, sub-maximal limit
at about 2/3 of the deficits that are considered.
Frailty index includes 40 variables [34].
 The Gérontopôle Frailty Screening Tool [35]: Two
different parts compose the instrument that has
been developed as a screening tool. The first one
appears as a questionnaire. Its main objective is to
attract the general practitioner’s attention to very
general signs and/or symptoms potentially indicating
the presence of an underlying frailty status. In the
second part, the general practitioner expresses his/
her own view about the frailty status of the
individual.
Specific tools are normally designed for specific pur-
poses. Consequently, when choosing a tool, one should
keep in mind the purpose for which the tool was origin-
ally designed [19].
Epidemiology of frailty
Frailty is very common in older people. According to
various studies, the prevalence of frailty in community-
dwelling elderly adults varies from 4.0% to 59.1% [21],
seems to increase with age, appears to be greater in
women than in men and is more prevalent in people,
with lower education and income, with poorer health
and higher rates of comorbid chronic disease and dis-
ability. Indeed, Collard’s meta-analysis [21] shows that
the average prevalence of frailty was statistically signifi-
cantly higher in women (9.6%, 95% CI: 9.2-10%) than in
men (5.2%, 95% CI: 4.9-5.5%) (p < .001). Another study
in 2010 [36] shows convergent results since the preva-
lence of frailty was higher in women (60.1%) than in
men (40.4%), (p < .001). This article also highlights that
the prevalence increases with each 5-year age group be-
fore reaching a “stable value” (15.3% among 65–69 years;
18.6% among 70–74 years; 23.5% among 75–79 years;
22.4% among 80–84 years; 20.2% over 85 years). Fried
[8] also notes that prevalence of frailty increases with
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among 71–74 years; 9.5% among 75–79 years; 16.3% among
80–85 years; 25.7% among 86–90 years; 23% over 90 years).
Furthermore, a recent survey of 7510 community-dwelling
older adults in 10 European countries found that preva-
lence of frailty was higher in southern than in northern
Europe which is consistent with an unexplained north–
south health risk gradient [37]. African Americans are
more likely to be frail than Caucasians [3,38]. Prevalence
of frailty seems higher among nursing home residents
than in community dwelling people with a general pooled
prevalence of 10.7% [21], and more specific values of
34.9% in a Polish cohort [39], 48% in a Canadian co-
hort [40], and 68% in a Spanish cohort [41]. This could
be explained because institutionalization could be a conse-
quence of frailty [42]. Finally, several studies show that the
prevalence of pre-frailty is around 47% [37,43,44] but no
consensus exists about the prevalence rates of frailty
[8,21,45,46]. The various definitions of frailty could partly
explain this discrepancies [47]. Indeed, the difference
between weighted rates of frailty according to physical
phenotype (9.9%) versus broad phenotype (13.6%) was
statistically significant [21].
Frailty is a dynamic process that can improve or worsen
over time [1,2] but worsening is more common than
improvement and the development of frailty frequently
results in a spiral of decline that leads not only to an in-
creased frailty status but also to a worsening disability,
falls, admission to hospital and even death. Epidemio-
logical data on transitions between frailty states (i.e. non-
frail, pre-frail, and frail) were first reported by Gill et al. in
a 4.5-year longitudinal study of 754 community-living
adults aged 70 years and above [25]. During the follow-up,
58% of participants had at least one transition between
any two of the three frailty states.
Screening frailty
Many instruments for evaluating frailty have been devel-
oped in recent years. While the concept of frailty is now
accepted by all, the introduction of screening in medical
practice remains controversial [1] and operational cri-
teria vary [24]. The choice of the screening tool for
frailty has to be based on the definition which will best
suit the needs of the researchers, clinicians or policy-
makers [20]. Around the world, many initiatives are set-
ting up screening for frailty and its management.
For example, a French national initiative, the HAS
[48], suggests implementing a screening for frailty among
people over 70 years old using the questionnaire elabo-
rated by the « Gérontopôle in Toulouse » for the identifi-
cation of frailty in primary care. Also, another French
initiative, the PAERPA [49], concerns people over 75 years
old and aims to identify and to prevent the risk of frailty.
In Japan, a screening approach is being carried out widelyusing the Kihon checklist developed by the Japanese
Ministry of Health [50].
To successfully combat frailty, we must implement the
screening and management of frailty into clinical practice
worldwide. From a public health point of view, the object-
ive of screening frailty would ultimately reduce overall
costs by reducing the rate of institutionalization and
hospitalization [51]. Reducing the severity of frailty will
provide large benefits for individuals, their families and for
the society. Frail elderly subjects receiving care to counter-
act frailty are more susceptible to have less cognitive or
functional decline, to present lower mortality rates and to
experience fewer falls.
Consequences of frailty
The frailty syndrome which makes individuals more vulner-
able to adverse health outcomes through generally subtle
and progressive physical changes, has attracted the atten-
tion of the medical and scientific communities as well as
the public health department of numerous countries [52].
The association between frailty and adverse outcomes
(falls, disability, hospitalization, care home admission and
mortality) has been reported in four large cohort studies:
– The Cardiovascular Health Study (CHS) showed a
predictive association between frailty and
intermediate frailty status with incident falls,
worsened mobility or activities of daily living (ADL)
disability, incident hospitalization and death over 3
or 7 years of follow up, with hazard ratio ranging
respectively from 1.82 to 4.46 and from 1.28 to 2.10
for the frail and intermediate groups [8].
– The Canadian Study of Health and Aging (CSHA)
highlighted that increasing frailty was associated
with an increased 5-year risk for death, with an odds
ratio of 4.82 (95% CI: 3.74 - 6.21) among mildly frail
people and 7.34 (95% CI 4.73- 11.38) among se-
verely frail people. Moreover, in this study, frailty
was the most important predictor of death and
institutionalization (Odds ratio: 7.28 (95% CI
5.01-10.58) among mildly frail people and 8.64
(95% CI 4.92-15.17) among severely frail people) [53].
This study therefore shows that the risk for adverse
health outcomes increased markedly with frailty and
these risks persist after adjustments for age, sex,
comorbid conditions, and poor self-rated health.
– The Women’s Health and Aging Study (WHAS)
showed, in agreement with analyses in the CHS, that
frailty strongly predicted all considered outcomes
except falls and first hospitalization. Indeed,
compared to robust individuals, frail women had a
6-fold higher risk of death and a more than 10-fold
higher risk of incident instrumental ADL (IADL)
and ADL disability and nursing home entry [54].
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that frailty was associated with increased odds of 2
or more falls in the subsequent year. Compared with
robust women, women in the intermediate group
had a 1.2- to 1.4-fold age-adjusted increase in risk
(P < .04) and frail women had a 2.4-fold increase in
risk (P < .001). Then, the odds of incident disability
(≥1 new IADL impairment) were greater with
increasing evidence of frailty. Compared with robust
women, women in the intermediate group had an
age-adjusted 1.8- to 1.9-fold increase in risk of
disability (P < .001) and frail women had a 2.2- to
2.9-fold increase in risk of disability (P < .001).
All-cause mortality rates were also higher with
increasing evidence of frailty. Compared with
robust women, women in the intermediate group
had an age-adjusted 1.4- to 1.5-fold increased risk
of death (P < .001) and frail women had a 2.4- to
2.7-fold increased risk of death (P < .001) [55].
Frail subjects are also at risk of iatrogenic disability
which is defined as the avoidable dependence which often
occurs during the course of care [56].
The way ahead
Reducing the severity of frailty is supposed to provide
large benefits for individuals, their families and for the
society. Treating frailty in older people seems a realistic
therapeutic and preventive goal. The lack of consensus
regarding the definition and the components of frailty
influences clinicians’ approach to intervention. Clinicians
should specifically identify and target the dimensions of
frailty identified with different assessment tools [57]. At
this time, from the current published literature, four
treatments appear to have potential to manage physical
components of frailty: exercise, caloric and protein sup-
port, vitamin D and reduction of polypharmacy [2].
Firstly, exercise has been showed to improve outcomes
of mobility and functional ability in two systematic re-
views of home-based and group-based exercise interven-
tions for frail elderly people [58,59]. Secondly, about the
caloric and protein support, weight loss is known to be a
major component of frailty [8], and caloric supplementa-
tions have enhanced weight gain and reduced mortality
and complications in various studies [2]. Furthermore,
some studies have suggested that protein supplementa-
tion could increase muscle mass, reduce complications,
improve grip strength and produce weight gain [60-62].
Thirdly, vitamin D supplementation for elderly people
who are deficient in the vitamin have reduced the num-
ber of falls and mortality even if the optimal modalities
have not yet been defined [1,63,64]. Fourthly, polyphar-
macy is recognized as a possible major contributor to
the pathogenesis of frailty [2]. Reducing medicationcould reduce costs and incidence of frailty among elderly
subjects [65].
Frailty and disability could be successfully treated using
an interdisciplinary multifaceted care program [66]. Van
de Rest showed that resistance-type exercise training in
combination with protein supplementation was beneficial
in the cognitive domain [67]. Another study showed that
multidisciplinary interventions, including exercises, nutri-
tional and psychological management had a positive effect
on various clinical outcomes for frail older people [57]. A
systematic review showed that overall interdisciplinary in-
terventions had a positive impact on residents’ outcomes
in nursing home settings [68].
It is assumed that early interventions with frail or pre-
frail people will improve quality of life and reduce costs
of care. Several approaches have already been investi-
gated in different clinical trials.
Discussion
Perspectives
Screening frailty and implementing early interventions
could prevent the risk of loss of autonomy and the oc-
currence of adverse health events of people aged 65 or
over, within 1 to 3 years [48]. In addition, the identifica-
tion of frail individuals could help in improving the
management of their comorbidities. Indeed, frail patients
appear to have specific care needs, beyond care of under-
lying or coincident comorbidities and associated disability.
Medical care for frail older adults needs to include ruling
out, and treatment of, pathologic causes of progressive
weakness, weight loss, decreased exercise tolerance, slo-
wed task performance (i.e. walking speed), and/or low ac-
tivity. Because frailty is a progressive condition that begins
with a preclinical stage [8] it offers the possibility of early
detection and thus of prevention.
It is admitted that frailty, because of the related ad-
verse events, is costly for the patient and the society.
However, few data exist on the potential financial gains
of screening for frailty and there is no evidence on the
economic implications of interventions targeting degree
of frailty in the frail population. Identification of cost-
effective interventions to reduce frailty may help health
services to more efficiently allocate health care resources
to those older people most at risk [69]. Identifying cost-
effective means for reducing frailty has the potential to
guide appropriate use of the limited resources available
to improve outcomes in older people. Therefore, further
data are needed and a cost-effectiveness study could fill
the gap in the literature.
Conclusions
Frailty has become a major health condition associated
with ageing, and it contributes to many components of
public health at both the patient and the societal levels.
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lished in the literature, and the concept almost universally
accepted, a clear consensus on the definition of frailty
does not emerge from the literature. Indeed, as this syn-
drome has been acknowledged to be a multidimensional
concept, the choice of the components to be included in
the frailty definition continues to be controversial. What-
ever the definition or the assessment tool used, the burden
of this syndrome and its costs for both the individual and
the society are of concern in our ageing population. It
seems thus essential for public health to implement the
screening and multidisciplinary treatments of frailty.
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